Cite
HARVARD Citation
Davis, S. et al. (2020). Low‐dose ibrutinib in the treatment of refractory pure red cell aplasia in chronic lymphocytic leukaemia. Internal medicine journal. 50 (8), pp. 1013-1015. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Davis, S. et al. (2020). Low‐dose ibrutinib in the treatment of refractory pure red cell aplasia in chronic lymphocytic leukaemia. Internal medicine journal. 50 (8), pp. 1013-1015. [Online].